Just another example of how ridiculously undervalued PYC is sitting on the ASX. I mean we've also said we're looking to get something in the clinic by year end. Clearly we haven't got the backing of a big pharma on a specific deal...yet... Then there are other irons in the fire, such as the latest JV with PhoreMost who could compete directly with Pepti, Uni QLD testing kits, other screening/test options, etc... but we sure as heck didn't get a $300m kick along to our value. Would be happy if we did, but alas... Just shows though that the value that could come from this one day when the market picks up on it.
Valuing PYC's science, page-43
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.015(11.1%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.0¢ | $660.5K | 5.132M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 411666 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 393465 | 9 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| PYC (ASX) Chart |